These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12784277)

  • 1. Tetrabenazine in the treatment of severe pediatric chorea.
    Chatterjee A; Frucht SJ
    Mov Disord; 2003 Jun; 18(6):703-6. PubMed ID: 12784277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrabenazine therapy of pediatric hyperkinetic movement disorders.
    Jain S; Greene PE; Frucht SJ
    Mov Disord; 2006 Nov; 21(11):1966-72. PubMed ID: 16958131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-term effect of tetrabenazine in the management of Huntington disease.
    Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR
    Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
    Savani AA; Login IS
    Neurology; 2007 Mar; 68(10):797; author reply 797. PubMed ID: 17339599
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of PANDAS treated with tetrabenazine and tonsillectomy.
    Fusco FR; Pompa A; Bernardi G; Ottaviani F; Giampà C; Laurenti D; Morello M; Bernardini S; Nuccetelli M; Sabatini U; Paolucci S
    J Child Neurol; 2010 May; 25(5):614-5. PubMed ID: 20207613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus.
    Sitburana O; Ondo WG
    Mov Disord; 2006 Nov; 21(11):2023-5. PubMed ID: 16986158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Hunter C; Jankovic J
    Mov Disord; 2007 Jan; 22(2):193-7. PubMed ID: 17133512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.
    Frank S; Ondo W; Fahn S; Hunter C; Oakes D; Plumb S; Marshall F; Shoulson I; Eberly S; Walker F; Factor S; Hunt V; Shinaman A; Jankovic J
    Clin Neuropharmacol; 2008; 31(3):127-33. PubMed ID: 18520979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
    Jankovic J; Clarence-Smith K
    Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrabenazine treatment in movement disorders.
    Paleacu D; Giladi N; Moore O; Stern A; Honigman S; Badarny S
    Clin Neuropharmacol; 2004; 27(5):230-3. PubMed ID: 15602104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrabenazine.
    Fasano A; Bentivoglio AR
    Expert Opin Pharmacother; 2009 Dec; 10(17):2883-96. PubMed ID: 19929707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
    Huntington Study Group
    Neurology; 2006 Feb; 66(3):366-72. PubMed ID: 16476934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Jankovic J
    Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of tetrabenazine in hyperkinetic movement disorders.
    Jankovic J; Beach J
    Neurology; 1997 Feb; 48(2):358-62. PubMed ID: 9040721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chorea in a patient with cerebral palsy: treatment with levetiracetam.
    Recio MV; Hauser RA; Louis ED; Radhashakar H; Sullivan KL; Zesiewicz TA
    Mov Disord; 2005 Jun; 20(6):762-4. PubMed ID: 15747368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
    Setter SM; Neumiller JJ; Dobbins EK; Wood L; Clark J; DuVall CA; Santiago A
    Consult Pharm; 2009 Jul; 24(7):524-37. PubMed ID: 19689181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrabenazine treatment for Huntington's disease-associated chorea.
    Ondo WG; Tintner R; Thomas M; Jankovic J
    Clin Neuropharmacol; 2002; 25(6):300-2. PubMed ID: 12469001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.